1mg ETH266
Pill imprint 1mg ETH266 has been identified as Doxazosin mesylate 1 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy.
Doxazosin 1 mg is not subject to the Controlled Substances Act.
See also related documents.
Doxazosin mesylate Images
- Imprint:
-
1mg
ETH266 - Strength:
- 1 mg
- Color:
- Gray
- Size:
- 9.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate
FD&C Blue No. 2 Aluminium Lake
FD&C Red No. 40 Aluminium Lake
FD&C Yellow No. 6 Aluminum Lake
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0266
| NDC Code | Manufacturer / Repackager |
|---|---|
| 67253-0380 | DAVA Pharmaceuticals, Inc. |
| 54569-5168 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Doxazosin Mesylate resources
- Doxazosin
- Doxazosin (Wolters Kluwer)
- Doxazosin Extended-Release Tablets (Wolters Kluwer)
- doxazosin (Cerner Multum)
- doxazosin (Micromedex) - Includes Dosage Information
- Doxazosin Mesylate (AHFS DI)
- Doxazosin (FDA)
- Doxazosin Mesylate (Wolters Kluwer)
Search Again
